Clinical Trials Directory

Trials / Completed

CompletedNCT02143284

A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical Technology

Single-Center, Exploratory Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing EndoChoice's Full Spectrum Optical Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
EndoChoice Innovation Center, Ltd. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

EndoChoice's FUSE System enables a wider view range via 1-2 additional cameras (depending on the model). These optical properties are to be examined and reviewed in this trial (mainly usability and safety)

Detailed description

EndoChoice Full Spectrum Optical Technology (FSOT) in gastrointestinal endoscopy enables a 330 degree field of view. FSOT powers EndoChoice's FDA, CE and AMAR (Israeli medical device authority) approved Endoscopic systems (Gastroscope and Colonoscope). The intent of this study is to evaluate the safety, performance and usability of additional versions of FSOT- powered gastroscopes and colonoscopes.

Conditions

Interventions

TypeNameDescription
DEVICEEndoscopy exploratory single arm (EndoChoice FUSE(TM) System)The investigational device will be applied in otherwise standard procedures (upper and lower Gastrointestinal tract endoscopy)

Timeline

Start date
2014-05-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2014-05-21
Last updated
2016-11-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02143284. Inclusion in this directory is not an endorsement.